Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism GSK-3β inhibitors(Glycogen synthase kinase-3 beta inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bipolar and Related Disorders | Preclinical | KR | 15 Jan 2009 | |
Diabetes Mellitus, Type 2 | Preclinical | KR | 15 Jan 2009 | |
Inflammation | Preclinical | KR | 15 Jan 2009 | |
Stroke | Preclinical | KR | 15 Jan 2009 |